Treatment response of Green Tea capsule, Intralesional inj. of Hyaluronidase, Dexamethasone, Placentrix and Sesame Oil Pulling in OSMF
Phase 4
- Conditions
- Health Condition 1: K135- Oral submucous fibrosis
- Registration Number
- CTRI/2021/05/033485
- Lead Sponsor
- Maulana Azad Institute of Dental Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Clinically and histopathologically proven cases of OSMF and OSCC. Subjects with prior informed consent.
Exclusion Criteria
Patients who are not willing to participate.
Patients with severe systemic disease.
Pregnant and nursing women.
Subjects with mouth opening less than 15 mm.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Mouth Opening, Tongue Protrusion, Cheek flexibility, VAS ScaleTimepoint: Pre-Treatment, 1 month, 3 months and at the end of 6 months
- Secondary Outcome Measures
Name Time Method Reporting of any malignant transformation in the span of 6 monthsTimepoint: Every 4 weeks till 6 months